Novel target gene identified for PTSD treatment

A study carried out at the Saban Research Institute of Children’s Hospital Los Angeles (CHLA; CA, USA) has identified a novel candidate gene that could act as a target for neurobiological and treatment studies of fear acquisition in trauma- and stress-related disorders such as PTSD. Findings were published in the Journal of Neuroscience. Trauma- and stress-related disorders, such as PTSD and anxiety, are widely variable in the severity of presented symptoms as well as in their response to treatment. Although such disorders are understood to have a substantial underlying genetic risk, the identified genes do not explain the clinical heterogeneity...